Welltech Ventures

Welltech Ventures is a venture capital firm based in Tel Aviv, Israel, established in 2019, that specializes in the wellness sector. It is recognized as the first and leading firm in Israel dedicated exclusively to this field. Welltech Ventures focuses on early-stage startups that leverage innovative technologies to enhance individual well-being and improve quality of life. The firm invests in a variety of areas, including remote care, preventive medicine, mental health, fitness, nutrition, sustainability, and longevity. With a strong emphasis on founder support, Welltech Ventures combines high-level expertise, a vast global network, and a dynamic culture to partner with Israel's most promising well-tech entrepreneurs.

Amir Alroy

Co-Founder, Partner

Steven Berelowitz

ADV., Partner

Galit Horovitz

Co-Founder, Partner

14 past transactions

Antidote Health

Series A in 2023
Antidote Health operates an AI-based health platform focused on improving access to healthcare and enhancing the patient experience. Its telemedicine application streamlines patient screening and supports doctors in their decision-making, alleviating administrative burdens typically associated with medical practice. This approach not only aims to provide affordable healthcare but also addresses social health aspects, fostering a positive ripple effect that extends from doctors to patients and their families, ultimately benefiting entire communities. By integrating technology and healthcare, Antidote Health seeks to elevate the quality of care while making it more accessible and efficient for all stakeholders involved.

MDI Health

Series A in 2023
MDI Health Technologies Ltd, established in 2018 and headquartered in Shoham, Israel, specializes in developing an AI-driven medication management system. This system collects and analyzes patient data, predicts medication risks and efficacies, suggests actionable insights, and monitors treatment progress. It serves patients, doctors, and clinical pharmacologists, aiding in preventing drug-related issues, optimizing medication therapy, and reducing healthcare costs.

Quris

Seed Round in 2022
Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.

Behavidence

Seed Round in 2022
Behavidence is a technology company that focuses on diagnosing and monitoring mental health conditions through the use of artificial intelligence. By analyzing subtle changes in phone usage patterns, Behavidence provides AI models for conditions such as Depression, Anxiety, Stress, ADHD, and PPD. The platform is designed for adoption by health organizations, technology firms, and government entities worldwide. Its applications extend beyond screening to include remote monitoring, detection of comorbidities, and assessment of therapeutic efficacy and potential relapses. Behavidence emphasizes user privacy, ensuring minimal burden on respondents while delivering real-time feedback. Through digital phenotyping and machine learning algorithms, the company offers high-accuracy tools to enhance the quality of care for users, caregivers, and clinical therapists.

Quris

Seed Round in 2022
Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.

Helping Hand

Seed Round in 2021
Helping Hand is a mental health platform based in Poland that provides personalized psychological support to individuals experiencing issues such as depression, anxiety, and stress. The platform features a comprehensive app that connects users with experienced and verified psychotherapists, offering valuable content and facilitating interactive meetings. This innovative service allows users to access a full range of mental health resources tailored to their specific needs, ensuring they receive the support necessary for their well-being.

Amkiri

Venture Round in 2021
Amkiri is a manufacturer of a unique beauty product that combines fragrance and visual elements, allowing for multi-sensory self-expression. The company has developed patented ink infused with alcohol-free, vegan, and cruelty-free perfumes that can be applied to the skin using specially designed applicators. This innovative ink not only offers a long-lasting scent but can also be easily removed with soap and water. By creating a product that merges the senses of smell and sight, Amkiri enables users to enhance their daily rituals with creativity and personal expression.

X-trodes

Seed Round in 2021
X-trodes is a technology start-up specializing in the development of innovative wearable and wireless technology for the advanced monitoring and analysis of biopotential signals. The company has created a scalable wireless electronic skin designed for precise electrophysiological monitoring. Its core technology offers objective and automated data collection with high resolution, making it suitable for clinical evaluation and treatment. This allows patients to assess the health of their brains, eyes, muscles, and hearts during both sleep and daily activities, ultimately aiming to enhance their quality of life.

Behavidence

Pre Seed Round in 2021
Behavidence is a technology company that focuses on diagnosing and monitoring mental health conditions through the use of artificial intelligence. By analyzing subtle changes in phone usage patterns, Behavidence provides AI models for conditions such as Depression, Anxiety, Stress, ADHD, and PPD. The platform is designed for adoption by health organizations, technology firms, and government entities worldwide. Its applications extend beyond screening to include remote monitoring, detection of comorbidities, and assessment of therapeutic efficacy and potential relapses. Behavidence emphasizes user privacy, ensuring minimal burden on respondents while delivering real-time feedback. Through digital phenotyping and machine learning algorithms, the company offers high-accuracy tools to enhance the quality of care for users, caregivers, and clinical therapists.

Amai Proteins

Funding Round in 2021
Amai Proteins is focused on revolutionizing the food and beverage industry by developing healthy and flavorful protein ingredients, particularly as sugar substitutes. The company specializes in Sweet Designer Proteins derived from naturally occurring sweet proteins found in the equatorial region. Using Agile Integrative Computational Protein Design and precision fermentation, Amai aims to create hyper-sweet designer proteins that are not only tasty and stable but also sustainable and cost-effective. This innovative approach enables the mass production of these protein ingredients, catering to the growing demand for healthier alternatives in the food market.

Antidote Health

Pre Seed Round in 2021
Antidote Health operates an AI-based health platform focused on improving access to healthcare and enhancing the patient experience. Its telemedicine application streamlines patient screening and supports doctors in their decision-making, alleviating administrative burdens typically associated with medical practice. This approach not only aims to provide affordable healthcare but also addresses social health aspects, fostering a positive ripple effect that extends from doctors to patients and their families, ultimately benefiting entire communities. By integrating technology and healthcare, Antidote Health seeks to elevate the quality of care while making it more accessible and efficient for all stakeholders involved.

Sency.

Seed Round in 2020
Using computer vision, Sency builds the brain of movement in order to drive people towards an active and healthy life. Founded in 2019, Sency created the See.Know.Guide (SKG) methodology. Using a mobile device camera, our unique algorithm understands movement thanks to massive data collection and expert knowledge. As a result, it provides real-time guidance and personalized plans. Sency's brain is constantly learning to serve with accurate actionable insights. Our technology is running on the Edge. All data is kept on the client’s device: no streaming to the cloud means no latency, no recording, and no chance of a breach of privacy. As a user-centric approach, Sency deploys interactive experiences on consumer devices only - no hardware required. Our first applications based on our core technology are the “Sency Health” and the “WODProof” apps. From health to fitness, Sency already helped 450,000 people worldwide to achieve their physical goals and keep continuing.

Amkiri

Venture Round in 2020
Amkiri is a manufacturer of a unique beauty product that combines fragrance and visual elements, allowing for multi-sensory self-expression. The company has developed patented ink infused with alcohol-free, vegan, and cruelty-free perfumes that can be applied to the skin using specially designed applicators. This innovative ink not only offers a long-lasting scent but can also be easily removed with soap and water. By creating a product that merges the senses of smell and sight, Amkiri enables users to enhance their daily rituals with creativity and personal expression.

Amai Proteins

Seed Round in 2020
Amai Proteins is focused on revolutionizing the food and beverage industry by developing healthy and flavorful protein ingredients, particularly as sugar substitutes. The company specializes in Sweet Designer Proteins derived from naturally occurring sweet proteins found in the equatorial region. Using Agile Integrative Computational Protein Design and precision fermentation, Amai aims to create hyper-sweet designer proteins that are not only tasty and stable but also sustainable and cost-effective. This innovative approach enables the mass production of these protein ingredients, catering to the growing demand for healthier alternatives in the food market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.